|
(Idiopathic) normal pressure hydrocephalus
|
0.010 |
Biomarker
|
disease |
BEFREE |
<sup>18</sup>F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus.
|
29876274 |
2018 |
|
Abdominal cocoon
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Demonstration of Tubercular "Abdominal Cocoon" (Sclerosing Encapsulating Peritonitis) in 18F-FDG PET/CT.
|
30106861 |
2018 |
|
Abnormal behavior
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
These findings require further confirmation in other preclinical models and patients with epilepsy and psychiatric disorders to address the value of [<sup>18</sup> F]FDG uptake as an imaging biomarker candidate for psychiatric comorbidities in patients as well as for severity assessment in rodent epilepsy models.
|
30370531 |
2018 |
|
Abnormal behavior
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
The model was applied to FDG PET data of Alzheimer's disease (AD) and mild cognitive impairment (MCI) and clinical routine FDG PET data for assessing behavioral abnormality and seizures.
|
31003928 |
2019 |
|
Abnormal behavior
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Although accurate differential diagnosis of dementia can be achieved by imaging disease-specific patterns of cerebral glucose metabolism with [F]fluorodeoxyglucose ([F]FDG)-PET, the diagnostic impact of [F]FDG-PET in primary psychiatric disorders is limited.
|
31107281 |
2019 |
|
Abscess
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The present case indicated that the possibility of abscesses should be considered with patients with PAVMs, and whole-body F-FDG PET/CT is suggested to identify possible accompanying abscesses in multiple organs for PAVMs patients.
|
29245306 |
2017 |
|
Abscess
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
FDG PET/CT was as sensitive as CT in identifying the six patients (19%) who developed abscesses.
|
28951990 |
2018 |
|
Absence of sensation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Five days after myocardial infarction, 18F-FDG PET was performed under anaesthesia with ketamine and xylazine (KX) to image the inflammatory response in the heart.
|
31835854 |
2019 |
|
ACTH Syndrome, Ectopic
|
0.010 |
Biomarker
|
disease |
BEFREE |
In Cushing disease patients, the pituitary maximum standardized uptake value F-FDG PET/CT (n=11) did not show significant differences compared with that in ectopic ACTH syndrome (EAS) patients (n=20).
|
30973841 |
2019 |
|
Acute appendicitis NOS (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG PET/CT Scan Can Predate Clinical Presentation in Acute Appendicitis.
|
28719443 |
2017 |
|
Acute Chest Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Fifty patients with acute coronary syndrome (ACS) and at least one lesion with <sup>18</sup> FDG uptake in the carotid artery (target-to-background ratio [TBR] ≥ 1.6) were randomly assigned to receive either fimasartan (60 mg once a day) or amlodipine (5 mg once a day).
|
30537083 |
2019 |
|
Acute Chest Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Dual time point FDG PET/CT imaging demonstrates that moderate-intensity statin therapy was insufficient in suppressed plaque inflammation within the first month after ACS in Asian patients, even though achieving target LDL levels.
|
30009378 |
2018 |
|
Acute Coronary Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Fifty patients with acute coronary syndrome (ACS) and at least one lesion with <sup>18</sup> FDG uptake in the carotid artery (target-to-background ratio [TBR] ≥ 1.6) were randomly assigned to receive either fimasartan (60 mg once a day) or amlodipine (5 mg once a day).
|
30537083 |
2019 |
|
Acute Coronary Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
In this 2-by-2 factorial trial, 50 patients with <sup>18</sup>FDG uptake (target-to-background ratio [TBR] ≥1.6) in the carotid artery and acute coronary syndrome were randomized to receive either simvastatin/ezetimibe 10/10 mg or rosuvastatin 10 mg. <sup>18</sup>FDG PET/CT examinations were performed at baseline and at 6 months.
|
31426749 |
2019 |
|
Acute GVH disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we present the findings of a whole-body <sup>18</sup>FDG PET/CT with extensive and multifocal involvement of the GIT in a patient that developed severe acute GVHD 93 days post autologous SCT for Hodgkin's lymphoma.
|
30326627 |
2018 |
|
Acute intermittent porphyria
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased FDG activity in extra-pancreatic bile duct was present in 4/26 of AIP patients, while was observed in none of the PC patients.
|
29061130 |
2017 |
|
Acute interstitial pneumonia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Increased FDG activity in extra-pancreatic bile duct was present in 4/26 of AIP patients, while was observed in none of the PC patients.
|
29061130 |
2017 |
|
Acute leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This study aims to improve the diagnostic performance of <sup>18</sup>F-FDG PET/CT in detecting BMI for patients with suspected relapsed AL.
|
31367253 |
2019 |
|
Acute lymphocytic leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
A 21-year-old woman who presented fatigue had a new diagnosis of acute lymphoblastic leukemia underwent FDG PET/CT.
|
29293135 |
2018 |
|
Acute lymphocytic leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
A 22-year-old woman with acute lymphoblastic leukemia underwent FDG PET/CT to evaluate possible extramedullary disease.
|
30004938 |
2018 |
|
Acute myocarditis
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG PET imaging can provide non-invasive serial monitoring of cardiac inflammation in a rat model of acute myocarditis.
|
30102319 |
2019 |
|
Acute pancreatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Back Pain in a Patient With Parotid Carcinoma: Serendipitous Discovery of Acute Pancreatitis as the Cause on 18F-FDG PET/CT.
|
29356746 |
2018 |
|
Acute pericarditis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We aimed to evaluate the prognostic value of FDG pericardial uptake using FDG-PET/CT in patients admitted for acute pericarditis with pericardial effusion.
|
29884293 |
2018 |
|
Acute pyelonephritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG PET/CT in Renal Infections: Evidence of Acute Pyelonephritis in a Horseshoe Kidney.
|
27879491 |
2017 |
|
Acute retention of urine
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
PET/CT imaging of <sup>18</sup>F-FDG-labeled CSC allows quantifying biodistribution and acute retention of implanted cells in a clinically relevant pig model of chronic myocardial infarction.
|
28288654 |
2017 |